Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Novo Nordisk reported in the press release that the 1-year extension period in the evoke and evoke+ trials will be discontinued based on the efficacy results observed in the overall study population. Further details about the topline results were presented yesterday at the Clinical Trials on Alzheimer's Disease Conference in San Diego, CA, and Novo Nordisk said in the news release that full results will be presented at the Alzheimers and Parkinsons Diseases Conferences in March 2026
Its also iron-free, as iron is not a mineral required by everyone and an excess of iron may be harmful
Neurological research has explored its effects in models of traumatic brain injury and spinal cord compression, with several studies reporting improved functional recovery versus vehicle controls
The prescribing labels for Ozempic and Wegovy recommend discussing the risks and benefits closely with your healthcare provider
